Table of Contents Table of Contents
Previous Page  461 / 1082 Next Page
Information
Show Menu
Previous Page 461 / 1082 Next Page
Page Background

S446

ESTRO 36 2017

_______________________________________________________________________________________________

Conclusion

Even though the analyzed IGRT protocol focuses entirely

on the gold seed of the prostate the needed margins for

the lymph nodes are only slightly larger than 5 mm which

in many centers are used as a standard PTV margin. Thus,

the additional margin needed to include the lymph nodes

is actually somewhat modest. However, the optimal

balance between dose coverage of tumor and lymph nodes

both in regard to local control and toxicity is still unclear,

and needs further investigation.

PO-0836 Impact of Deep Inspiration Breath Hold on

Left Anterior Coronary dose in Left Breast irradiation.

F. Azoury

1

, S. Achkar

1

, N. Farah

1

, D. Nasr

1

, C. El Khoury

1

,

N. Khater

1

, J. Barouky

1

, R. Sayah

1

, E. Nasr

1

1

Hotel Dieu de France Hospital - Saint Joseph University,

Radiation Oncology, Beirut, Lebanon

Purpose or Objective

Irradiation of Left breast cancer exposes women to higher

doses to the heart and LAD coronary. Blocking the heart in

the tangent fields will inevitably cause under dosage in

proximity to the tumor bed. Here we evaluate the effect

of deep inspiration breath hold (DIBH) on the coverage of

the whole breast and the reduction of heart and LAD

doses.

Material and Methods

We performed a dosimetric study on 25 patients treated

with DIBH for left breast cancer utilizing RPM (Varian

Medical Systems). Treatment plans were generated in Free

Breathing (FB) and DIBH. Optimization was done with 3D

Field-in-Field technique utilizing two-tangent setup. Care

was taken to cover the whole breast volume. Prescription

dose was 50Gy in 25 fractions. Planning objectives were:

near minimum dose (D98) > 90% (45Gy), near maximum

dose (D2) <105% and a median dose of 50Gy. Doses to the

heart, LAD and left lung were compiled, left breast

coverage was evaluated, and statistical analysis was

performed using Student T-test with a 95% Interval of

confidence.

Results

Left breast results: Identical coverage was achieved with

a D95 of 95.2% ±0.4 (DIBH) vs. D95= 95.4%±0.6

(FB)(p=0.27). No statistical difference were found in D98,

median and D2 (Figure1.A). Left lung results: No statistical

difference was also found (Figure1.B). Heart results: Doses

were significantly lower with DIBH; Dmean at 1.5Gy±0.8

(DIBH) vs. 2.9Gy±1.6 (FB) (p<0.001) and Dmax at

36.3Gy±14.7 (DIBH) vs. 46.2Gy±6.6 (FB) (p=0.004). DVH

metrics for V10, V20, V30, and V40 were all significantly

better in DIBH (Figure1.C). LAD coronary results: Doses

were significantly lower with DIBH with Dmean at 9.5Gy ±

7.2 (DIBH) vs. 21.8Gy±11.4 (FB) (p<0.001) and a Dmax at

29.2Gy±17 (DIBH) vs. 42.3Gy±12 (FB) (p=0.003). DVH

metrics favored the DIBH plans significantly all across the

range of doses (Figure.1D).

Conclusion

In the treatment left breast cancer, 3D-DIBH showed

superior dosimetric advantages in comparison to 3D-FB.

Both heart and LAD were significantly spared without

compromising left breast coverage. The LAD was spared

for doses ranging from the low dose spectrum to the

highest dose.

PO-0837 Dosimetric advantages afforded by Dynamic

WaveArc therapy accelerated partial breast irradiation

Y. Ono

1

, M. Yoshimura

1

, K. Hirata

1

, N. Mukumoto

1

, T.

Ono

1

, M. Inoue

1

, M. Ogura

1

, T. Mizowaki

1

, M. Hiraoka

2

1

Kyoto University- Graduate School of Medicine,

Department of Radiation Oncology and Image-applied

Therapy, Kyoto, Japan

2

Japanese Red Cross Wakayama Medical Center,

Department of Radiation Oncology, Wakayama, Japan

Purpose or Objective

We identify dosimetric advantages of the novel volumetric

modulated arc therapy (VMAT) featuring continuously

varying non-coplanar trajectories. This is the Dynamic

WaveArc (DWA) therapy used for accelerated partial

breast irradiation (APBI). The dose distribution of DWA

therapy was compared to that of non-coplanar three-

dimensional conformal radiotherapy (3D-CRT) and

coplanar VMAT.

Material and Methods

We evaluated APBI dose distributions, delivered via DWA,

in 24 left-side breast cancer patients via non-coplanar 3D-

CRT from November 2011 to April 2016 at our institution.

The prescribed dose was 38.5 Gy in 10 fractions. The

Vero4DRT enables DWA by continuous gantry rotation and

O-ring skewing with moving dynamic multi-leaf collimator

(MLC). Thus, the Vero4DRT delivers non-coplanar VMAT

without couch rotation, minimizing dose delivery to

adjacent organs at risk (OARs). We created two sets of 11

control points (at angles 315-35° to the O-ring angle, and

110-155° and 290-355° to the gantry angle), for two non-

coplanar DWA trajectories. DWA, non-coplanar 3D-CRT,

and coplanar VMAT treatment plans were created by a

clinical treatment planning system, Raystation, using a

collapsed cone dose-calculation algorithm (Figure 1-A).

The mean DWA doses to the planning target volume (PTV),

the bilateral breasts, the lungs, the heart, the left